|
|
|
Insider
Information: |
Gross Phillip |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
133,228,723 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$3,815,619,731 |
|
|
Total
Shares |
133,228,723 |
|
|
Total
Value |
$3,815,619,731 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
24
|
66
|
Stock
price went up :
|
8
|
10
|
Stock
price went down : |
16
|
56
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-3.8%
|
-765.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boulder Brands Inc |
BDBD |
10% Owner |
2007-09-07 |
0 |
2013-02-01 |
5,939,492 |
Premium* |
|
Hubbell Inc |
HUBB |
10% Owner |
|
0 |
2008-04-25 |
727,000 |
Premium* |
|
Pacific Sunwear Of California Inc |
PSUN |
10% Owner |
2008-07-11 |
0 |
2016-04-06 |
5,127,926 |
Premium* |
|
Sleep Number Corp |
SCSS |
See Remarks. |
|
0 |
2011-02-09 |
5,415,000 |
Premium* |
|
Celanese Corp |
CE |
10% Owner |
|
0 |
2009-02-02 |
13,588,774 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2009-03-04 |
0 |
2015-01-09 |
2,546,592 |
Premium* |
|
Correvio Pharma Corporation |
CORV |
10% Owner |
2009-04-09 |
0 |
2010-04-14 |
6,700,000 |
Premium* |
|
Mandalay Digital Group Inc |
MNDL |
10% Owner |
|
0 |
2012-03-01 |
10,053,333 |
Premium* |
|
Puma Biotechnology Inc |
PBYI |
10% Owner |
2012-04-26 |
0 |
2017-06-12 |
3,696,580 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-20 |
510,147 |
Premium* |
|
HeartWare International Inc |
HTWR |
10% Owner |
|
0 |
2015-08-03 |
1,722,969 |
Premium* |
|
Calithera Biosciences, Inc. |
CALA |
10% Owner |
|
0 |
2017-09-28 |
3,546,873 |
Premium* |
|
Advaxis Inc |
ADXS |
10% Owner |
|
0 |
2017-10-11 |
4,100,043 |
Premium* |
|
Nexvet Biopharma Plc |
NVET |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
875,000 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
10% Owner |
|
0 |
2015-10-15 |
2,539,949 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
|
0 |
2016-09-14 |
2,375,000 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
2017-03-17 |
0 |
2017-03-17 |
675,000 |
Premium* |
|
Solaris Oilfield Infrastructure,... |
SOI |
10% Owner |
2017-05-12 |
0 |
2017-05-12 |
1,275,000 |
Premium* |
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
|
0 |
2017-05-30 |
2,056,076 |
Premium* |
|
Orbcomm Inc. |
ORBC |
10% Owner |
|
0 |
2020-08-12 |
7,697,220 |
Premium* |
|
Royalty Pharma Plc |
RPRX |
10% Owner |
2020-06-18 |
0 |
2020-12-18 |
38,714,280 |
Premium* |
|
Advent Technologies Holdings Ord... |
ADN |
10% Owner |
|
0 |
2020-12-03 |
781,535 |
Premium* |
|
Gcm Grosvenor Inc. |
GCMG |
10% Owner |
2021-05-18 |
0 |
2023-05-10 |
4,158,641 |
Premium* |
|
Abacus Life Ord Shs Class A |
ABL |
10% Owner |
|
0 |
2023-01-23 |
0 |
Premium* |
|
Abeona Therapeutics Inc |
ABEO |
10% Owner |
|
0 |
2023-07-03 |
3,249,994 |
Premium* |
|
EyePoint Pharmaceuticals Inc |
EYPT |
10% Owner |
|
0 |
2024-04-18 |
5,156,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
293 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-10 |
4 |
B |
$10.50 |
$152,750 |
I/I |
14,554 |
4,759,833 |
1.5 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-11 |
4 |
B |
$10.24 |
$925,056 |
I/I |
90,000 |
4,849,833 |
1.5 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-14 |
4 |
B |
$10.00 |
$646,313 |
I/I |
63,594 |
4,913,427 |
1.5 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-16 |
4 |
B |
$10.15 |
$66,604 |
I/I |
6,562 |
4,919,989 |
1.5 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-18 |
4 |
B |
$10.15 |
$28,601 |
I/I |
2,818 |
4,922,807 |
1.5 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-21 |
4 |
B |
$10.20 |
$203,740 |
I/I |
19,979 |
4,942,786 |
1.5 |
% |
|
ABL |
Abacus Life Ord Shs Class... |
10% Owner |
|
2023-01-23 |
4 |
D |
$10.21 |
$23,975,265 |
I/I |
(2,348,214) |
0 |
0 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-04-26 |
4 |
S |
$7.83 |
$625,085 |
I/I |
(79,832) |
4,862,954 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-04-27 |
4 |
S |
$7.95 |
$393,981 |
I/I |
(49,553) |
4,813,401 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-04-28 |
4 |
S |
$8.11 |
$893,444 |
I/I |
(110,128) |
4,703,273 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-03 |
4 |
S |
$7.91 |
$1,402,063 |
I/I |
(177,252) |
4,526,021 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-03 |
4 |
S |
$8.04 |
$402,000 |
I/I |
(50,000) |
4,476,021 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-05 |
4 |
S |
$7.56 |
$665,068 |
I/I |
(87,972) |
4,388,049 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-08 |
4 |
S |
$7.82 |
$547,526 |
I/I |
(70,000) |
4,318,049 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-09 |
4 |
S |
$7.69 |
$335,260 |
I/I |
(43,560) |
4,274,489 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-10 |
4 |
S |
$7.34 |
$849,114 |
I/I |
(115,578) |
4,158,641 |
0 |
% |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2012-07-25 |
4/A |
B |
$12.50 |
$5,625,000 |
I/I |
450,000 |
4,432,519 |
1.5 |
- |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2012-07-25 |
4/A |
B |
$12.00 |
$184,800 |
I/I |
15,400 |
3,982,519 |
1.5 |
- |
|
293 Records found
|
|
Page 12 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|